| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.12B | 20.93B | 25.07B | 32.54B | 20.52B | 16.64B |
| Gross Profit | 6.05B | 8.16B | 9.10B | 9.15B | 5.16B | 5.07B |
| EBITDA | 5.32B | 5.42B | 3.49B | 5.40B | 3.60B | 3.34B |
| Net Income | 2.19B | 1.89B | 742.00M | 2.54B | 1.44B | 1.39B |
Balance Sheet | ||||||
| Total Assets | 37.07B | 37.34B | 41.28B | 49.96B | 39.97B | 32.06B |
| Cash, Cash Equivalents and Short-Term Investments | 196.00M | 840.00M | 2.11B | 7.14B | 1.58B | 1.58B |
| Total Debt | 10.72B | 10.58B | 13.73B | 18.49B | 10.38B | 4.26B |
| Total Liabilities | 27.24B | 28.29B | 34.08B | 44.20B | 34.42B | 24.60B |
| Stockholders Equity | 8.66B | 8.11B | 7.02B | 5.56B | 5.38B | 7.32B |
Cash Flow | ||||||
| Free Cash Flow | 2.66B | 1.72B | 2.41B | -460.00M | 539.00M | 1.25B |
| Operating Cash Flow | 4.49B | 3.57B | 4.70B | 1.67B | 2.62B | 2.95B |
| Investing Cash Flow | -2.73B | -1.33B | 3.19B | -8.16B | -3.07B | -1.73B |
| Financing Cash Flow | -3.89B | -3.50B | -6.65B | 6.65B | 752.00M | -1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | €22.60B | 12.39 | 22.84% | 6.66% | 2.66% | 1.26% | |
67 Neutral | €121.23B | 21.27 | 11.50% | 2.92% | 0.50% | -19.06% | |
66 Neutral | €7.10B | 9.50 | 13.06% | 2.02% | 2.05% | 307.60% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | €32.31B | 14.63 | 26.20% | 4.32% | -2.54% | 103.14% | |
55 Neutral | €3.63B | 38.66 | 3.85% | 7.01% | 5.35% | ― | |
52 Neutral | €8.05B | 21.89 | 10.14% | 4.27% | -23.15% | -39.13% |